| 摘要 |
<p>The present invention relates to a pharmaceutical composition containing a combination of a leukotriene receptor antagonist and a histamine H4 receptor antagonist, wherein the leukotriene receptor antagonist is particularly selected from montelukast, pranlukast and zafirlukast. The composition can be used for treating an allergic and/or inflammatory condition, such as seasonal and perennial allergic rhinitis, non-allergic rhinitis, asthma, COPD, sinusitis, colds, dermatitis and uriticaria.</p> |
